Search for the Cause

After two years of not-quite-right diagnoses, Matt and Cristina Might enrolled their son in a genome sequencing study aimed at finding the genetic basis of rare diseases, the New Yorker's Seth Mnookin reports. Bertrand Might, as Mnookin describes, suffers from movement issues, seizures, and the inability to make tears, among other symptoms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.